Results 201 to 210 of about 1,041,807 (313)

Cost‐Effectiveness of an Antibacterial Envelope in Patients at High Risk of Cardiac Implantable Electronic Device Infection in the Australian Public Healthcare System [PDF]

open access: yesJ Arrhythm
Use of an antibacterial envelope in patients at high risk of infection implanted with a cardiac implantable electronic device results in a reduction in infection and an increased quality of life. The incremental cost‐effectiveness ratio is dominant (increases quality of life without increasing cost).
Hill M   +7 more
europepmc   +2 more sources

Noradrenergic and cholinergic innervation of the normal human heart and changes associated with cardiomyopathy

open access: yesThe Anatomical Record, Volume 309, Issue 2, Page 417-450, February 2026.
Abstract Autonomic nerves are crucial in cardiac function and pathology. However, data on the distribution of cholinergic and noradrenergic nerves in normal and pathologic human hearts is lacking. Nonfailing donor hearts were pressure‐perfusion fixed, imaged, and dissected. Left ventricular cardiomyopathy samples were also obtained.
Peter Hanna   +16 more
wiley   +1 more source

Drug‐Resistant Sinus Tachycardia as a Dose‐Dependent Side Effect of Spironolactone: A Case Report and Review of the Literature

open access: yesClinical Case Reports, Volume 14, Issue 2, February 2026.
ABSTRACT Spironolactone is widely used for polycystic ovarian syndrome due to its anti‐androgenic properties. However, rare cardiovascular side effects may occur even in normotensive patients. We report a case of severe palpitations and drug‐resistant sinus tachycardia following high‐dose therapy, emphasizing the need for cautious titration and cardiac
Zahra Abdi   +3 more
wiley   +1 more source

PLASMA Chile: A prospective, multicenter observational cohort study of patients with heart failure and reduced left ventricular ejection fraction. [PDF]

open access: yesHeart Rhythm O2
Aguayo R   +10 more
europepmc   +1 more source

Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.

open access: yesNew England Journal of Medicine, 2000
B. Maron   +14 more
semanticscholar   +1 more source

Patient‐Specific Lumped‐Parameter Model for Quantifying Vessel‐Specific Remodeling and Predicting Right Ventricular Function in Pulmonary Hypertension

open access: yesComprehensive Physiology, Volume 16, Issue 1, February 2026.
Personalized, patient‐specific biophysical model enabling mechanistic assessment of right ventricular (RV) function as well as robust differentiation of pulmonary hypertension (PH) subtype from routine clinical measurements of pulmonary arterial pressure and flow.
Christopher G. Lechuga   +5 more
wiley   +1 more source

MRI and Implant Safety at Low‐Field and Ultralow‐Field Strengths

open access: yesJournal of Magnetic Resonance Imaging, Volume 63, Issue 2, Page 364-377, February 2026.
ABSTRACT Despite its unequivocal value in radiological diagnosis, access to conventional high‐field MRI systems remains extremely uneven across the world. Access is particularly limited in underfunded and remote settings, due to the high cost and infrastructure requirements of MRI systems.
Emre Kopanoglu   +7 more
wiley   +1 more source

Exercise-guided programming of a subcutaneous implantable cardioverter-defibrillator in an athlete. [PDF]

open access: yesHeartRhythm Case Rep
Hsieh PN   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy